A nanotheranostic agent based on Nd<sup>3+</sup>-doped YVO<sub>4</sub> with blood-brain-barrier permeability for NIR-Ⅱ fluorescence imaging/magnetic resonance imaging and boosted sonodynamic therapy of orthotopic glioma

Zhijia Lv; Longhai Jin; Yue Cao; Hao Zhang; Dongzhi Xue; Na Yin; Tianqi Zhang; Yinghui Wang; Jianhua Liu; Xiaogang Liu; Hongjie Zhang

doi:10.1038/s41377-022-00794-9

Go to Nature Website

Your Location：

Home >

Browse articles >

A nanotheranostic agent based on Nd³⁺-doped YVO₄ with blood-brain-barrier permeability for NIR-Ⅱ fluorescence imaging/magnetic resonance imaging and boosted sonodynamic therapy of orthotopic glioma

Articles

- A nanotheranostic agent based on Nd³⁺-doped YVO₄ with blood-brain-barrier permeability for NIR-Ⅱ fluorescence imaging/magnetic resonance imaging and boosted sonodynamic therapy of orthotopic glioma
- A nanotheranostic agent based on Nd³⁺-doped YVO₄ with blood-brain-barrier permeability for NIR-Ⅱ fluorescence imaging/magnetic resonance imaging and boosted sonodynamic therapy of orthotopic glioma
- LSA 2022年11卷第6期页码：1088-1097
- Affiliations：
  
  1.State Key Laboratory of Rare Earth Resource Utilization, Changchun Institute of Applied Chemistry (CIAC), Chinese Academy of Sciences, 130022, Changchun, China
  2.University of Science and Technology of China, 230026, Hefei, Anhui, China
  3.Ganjiang Innovation Academy, Chinese Academy of Sciences, 341000, Ganzhou, Jiangxi, China
  4.Department of Radiology, The Second Hospital of Jilin University, 130041, Changchun, China
  5.Department of Neurosurgery, The First Hospital of Jilin University, 130041, Changchun, China
  6.Department of Chemistry, National University of Singapore, Singapore, 117543, Singapore
  7.Department of Chemistry, Tsinghua University, 100084, Beijing, China
- Author bio：
  
  Yinghui Wang (yhwang@ciac.ac.cn)
  Jianhua Liu (drliujh@yahoo.com)
  Hongjie Zhang (hongjie@ciac.ac.cn)
- Funds：
- DOI：10.1038/s41377-022-00794-9
  中图分类号：
- 纸质出版日期：2022-06-30，
  
  网络出版日期：2022-04-29，
  
  收稿日期：2021-12-22，
  
  修回日期：2022-03-31，
  
  录用日期：2022-04-08
- Accepted：
Scan QR Code
A nanotheranostic agent based on Nd³⁺-doped YVO₄ with blood-brain-barrier permeability for NIR-Ⅱ fluorescence imaging/magnetic resonance imaging and boosted sonodynamic therapy of orthotopic glioma[J]. LSA, 2022,11(6):1088-1097.

Lv, Z. J. et al. A nanotheranostic agent based on Nd³⁺-doped YVO₄ with blood-brain-barrier permeability for NIR-Ⅱ fluorescence imaging/magnetic resonance imaging and boosted sonodynamic therapy of orthotopic glioma. Light: Science & Applications, 11, 1088-1097 (2022).
A nanotheranostic agent based on Nd³⁺-doped YVO₄ with blood-brain-barrier permeability for NIR-Ⅱ fluorescence imaging/magnetic resonance imaging and boosted sonodynamic therapy of orthotopic glioma[J]. LSA, 2022,11(6):1088-1097. DOI： 10.1038/s41377-022-00794-9.

Lv, Z. J. et al. A nanotheranostic agent based on Nd³⁺-doped YVO₄ with blood-brain-barrier permeability for NIR-Ⅱ fluorescence imaging/magnetic resonance imaging and boosted sonodynamic therapy of orthotopic glioma. Light: Science & Applications, 11, 1088-1097 (2022). DOI： 10.1038/s41377-022-00794-9.

摘要

Abstract

The specific diagnosis and treatment of gliomas is a primary challenge in clinic due to their high invasiveness and blood-brain barrier (BBB) obstruction. It is highly desirable to find a multifunctional agent with good BBB penetration for precise theranostics. Herei

we design and construct a core-shell structured nanotheranostic agent (YVO

: Nd

-HMME@MnO

-LF

marked as YHM) with YVO

: Nd

particles as the core and MnO

nanosheets as the shell. Sonosensitizer hematoporphyrinmonomethyl ether (HMME) and lactoferrin (LF) were further loaded and modified on the surface

giving it a good ability to cross the BBB

near-infrared fluorescence imaging in the second window (NIR-Ⅱ)/magnetic resonance imaging (MRI) bimodality

and highly efficient sonodynamic therapy (SDT) of orthotopic gliomas. The YVO

: Nd

(25%) core exhibited good NIR-Ⅱ fluorescence properties

enabling YHM to act as promising probes for NIR-Ⅱ fluorescence imaging of vessels and orthotopic gliomas. MnO

shell can not only provide O

in the tumor microenvironments (TME) to significantly improve the healing efficacy of SDT

but also release Mn

ions to achieve T

-weight MRI in situ. Non-invasive SDT can effectively restrain tumor growth. This work not only demonstrates that multifunctional YHM is promising for diagnosis and treatment of orthotopic glioma

but also provides insights into exploring the theranostic agents based on rare earth-doped yttrium vanadate nanoparticles.

关键词

Keywords

references

Zhang, H. et al. Second near-infrared photodynamic therapy and chemotherapy of orthotopic malignant glioblastoma with ultra-small Cu2-xSe nanoparticles.Nanoscale11, 7600–7608 (2019)..

Wang, X. C. et al. Albumin-mediated synthesis of fluoroperovskite KMnF3nanocrystals forT1-T2dual-modal magnetic resonance imaging of brain gliomas with improved sensitivity.Chem. Eng. J.395, 125066 (2020)..

Gao, H. Y. et al. In situ formation of nanotheranostics to overcome the blood-brain barrier and enhance treatment of orthotopic glioma.ACS Appl. Mater. Interfaces12, 26880–26892 (2020)..

Gong, F. et al. Core-shell TaOx@MnO2nanoparticles as a nano-radiosensitizer for effective cancer radiotherapy.J. Mater. Chem. B6, 2250–2257 (2018)..

Feng, W. et al. Nanocatalysts-augmented and photothermal-enhanced tumor-specific sequential nanocatalytic therapy in both NIR-Ⅰ and NIR-Ⅱ biowindows.Adv. Mater.31, 1805919 (2019)..

Huang, H. B. et al. Dual-response CuS@MnO2nanoparticles with activatable CT/MR-enhanced in vivo imaging guided photothermal therapy.RSC Adv.9, 2718–2730 (2019)..

Fan, Y.&Zhang, F. A new generation of NIR-Ⅱ probes: lanthanide-based nanocrystals for bioimaging and biosensing.Adv. Optical Mater.7, 1801417 (2019)..

Ding, F. et al. A nano-cocktail of an NIR-Ⅱ emissive fluorophore and organoplatinum(Ⅱ) metallacycle for efficient cancer imaging and therapy.Chem. Sci.10, 7023–7028 (2019)..

He, J. J. et al. Plasmonic enhancement and polarization dependence of nonlinear upconversion emissions from single gold nanorod@SiO2@CaF2: Yb3+, Er3+hybrid core-shell-satellite nanostructures.Light. : Sci. Appl.6, e16217 (2017)..

Dai, H. M. et al. Small molecular NIR-Ⅱ fluorophores for cancer phototheranostics.Innovation2, 100082 (2021)..

Dai, Y. F. et al. Metastatic status of sentinel lymph nodes in breast cancer determined with photoacoustic microscopy via dual-targeting nanoparticles.Light. : Sci. Appl.9, 164 (2020)..

Sheng, Z. H. et al. Bright aggregation-induced-emission dots for targeted synergetic NIR-Ⅱ fluorescence and NIR-Ⅰ photoacoustic imaging of orthotopic brain tumors.Adv. Mater.30, 1800766 (2018)..

Pan, T. et al. Biophotonic probes for bio-detection and imaging.Light. : Sci. Appl.10, 124 (2021)..

Lian, W. et al. Broadband excitable NIR-Ⅱ luminescent nano-bioprobes based on CuInSe2quantum dots for the detection of circulating tumor cells.Nano Today35, 100943 (2020)..

Del Rosal, B. et al. In vivo contactless brain nanothermometry.Adv. Funct. Mater.28, 1806088 (2018)..

Ren, F. et al. Engineering NIR-Ⅱb fluorescence of Er-based lanthanide nanoparticles for through-skull targeted imaging and imaging-guided surgery of orthotopic glioma.Nano Today34, 100905 (2020)..

Song, D. et al. Sensitizing the luminescence of lanthanide-doped nanoparticles over 1500 nm for high-contrast and deep imaging of brain injury.Anal. Chem.93, 7949–7957 (2021)..

Kolesnikov, I. E. et al. Concentration effect on structural and luminescent properties of YVO4: Nd3+nanophosphors.Mater. Res. Bull.70, 799–803 (2015)..

Zeng, H. H. et al. Design and synthesis of a vanadate-based ratiometric fluorescent probe for sequential recognition of Cu2+ions and biothiols.Analyst144, 7368–7377 (2019)..

Singh, L. P. et al. Hybrid nanomaterials YVO4: Eu/Fe3O4for optical imaging and hyperthermia in cancer cells.J. Mater. Chem. C3, 1965–1975 (2015)..

Wang, C. X. et al. Camouflaging nanoparticles with brain metastatic tumor cell membranes: a new strategy to traverse blood–brain barrier for imaging and therapy of brain tumors.Adv. Funct. Mater.30, 1909369 (2020)..

Yin, Y. T. et al. A pH-sensitive hyaluronic acid prodrug modified with lactoferrin for glioma dual-targeted treatment.Mater. Sci. Eng. : C.67, 159–169 (2016)..

Feng, Q. H. et al. pH/ultrasound dual-responsive gas generator for ultrasound imaging-guided therapeutic inertial cavitation and sonodynamic therapy.Adv. Healthc. Mater.7, 1700957 (2018)..

Gao, F. L. et al. Titania-coated 2D gold nanoplates as nanoagents for synergistic photothermal/sonodynamic therapy in the second near-infrared window.Nanoscale11, 2374–2384 (2019)..

Gong, F. et al. Ultrasmall oxygen-deficient bimetallic oxide MnWOxnanoparticles for depletion of endogenous GSH and enhanced sonodynamic cancer therapy.Adv. Mater.31, 1900730 (2019)..

Ni, D. L. et al. Single Ho3+-doped upconversion nanoparticles for high-performanceT2-weighted brain tumor diagnosis and MR/UCL/CT multimodal imaging.Adv. Funct. Mater.24, 6613–6620 (2014)..

Ming, J. et al. Pd@Pt-GOx/HA as a novel enzymatic cascade nanoreactor for high-efficiency starving-enhanced chemodynamic cancer therapy.ACS Appl. Mater. Interfaces12, 51249–51262 (2020)..

Liu, Y. et al. Defect modified zinc oxide with augmenting sonodynamic reactive oxygen species generation.Biomaterials251, 120075 (2020)..

Jin, L. H. et al. MnO2-functionalized Co-P nanocomposite: a new theranostic agent for pH-triggered T1/T2dual-modality magnetic resonance imaging-guided chemo-photothermal synergistic therapy.ACS Appl. Mater. Interfaces9, 41648–41658 (2017)..

Xu, J. T. et al. Tumor microenvironment-responsive mesoporous MnO2-coated upconversion nanoplatform for self-enhanced tumor theranostics.Adv. Funct. Mater.28, 1803804 (2018)..

Tammam, S. N., Azzazy, H. M. E.&Lamprecht, A. Nuclear and cytoplasmic delivery of lactoferrin in glioma using chitosan nanoparticles: cellular location dependent-action of lactoferrin.Eur. J. Pharmaceutics Biopharmaceutics129, 74–79 (2018)..

Tomitaka, A. et al. Lactoferrin conjugated iron oxide nanoparticles for targeting brain glioma cells in magnetic particle imaging.Nanoscale7, 16890–16898 (2015)..

Liu, S. et al. Antitumor efficacy of Lf modified daunorubicin plus honokiol liposomes in treatment of brain glioma.Eur. J. Pharm. Sci.106, 185–197 (2017)..

Zhang, J. et al. Upconversion red emission and near-infrared quantum-cutting persistent luminescence of Nd3+-activated Ca2SnO4induced by Yb3+.J. Phys. Chem. C124, 19774–19780 (2020)..

Zeng, H. H. et al. In situ synthesis of MnO2/porous graphitic carbon composites as high-capacity anode materials for lithium-ion batteries.Energy Fuels34, 2480–2491 (2020)..

Li, Y. J. et al. Neutrophil delivered hollow titania covered persistent luminescent nanosensitizer for ultrosound augmented chemo/immuno glioblastoma therapy.Adv. Sci.8, 2004381 (2021)..

Amiri, P. et al. Erythrocytes, a new contributor to age-associated loss of blood-brain barrier integrity.Adv. Sci.8, 2101912 (2021)..

浏览量

Downloads

CSCD

文章被引用时，请邮件提醒。

Submit

工具集

关联资源

暂无数据

A nanotheranostic agent based on Nd3+-doped YVO4 with blood-brain-barrier permeability for NIR-Ⅱ fluorescence imaging/magnetic resonance imaging and boosted sonodynamic therapy of orthotopic glioma

A nanotheranostic agent based on Nd3+-doped YVO4 with blood-brain-barrier permeability for NIR-Ⅱ fluorescence imaging/magnetic resonance imaging and boosted sonodynamic therapy of orthotopic glioma

DOI：10.1038/s41377-022-00794-9

摘要

Abstract

关键词

Keywords

references

A nanotheranostic agent based on Nd³⁺-doped YVO₄ with blood-brain-barrier permeability for NIR-Ⅱ fluorescence imaging/magnetic resonance imaging and boosted sonodynamic therapy of orthotopic glioma

A nanotheranostic agent based on Nd³⁺-doped YVO₄ with blood-brain-barrier permeability for NIR-Ⅱ fluorescence imaging/magnetic resonance imaging and boosted sonodynamic therapy of orthotopic glioma